| 标题 |
First-line treatment with chemotherapy, surufatinib (an angio-immuno kinase inhibitor), and camrelizumab (an anti-PD-1 antibody) for locally advanced or metastatic pancreatic ductal adenocarcinoma: a phase Ib/II randomized study |
| 网址 | |
| DOI | |
| 其它 |
期刊:Signal Transduction and Targeted Therapy 作者:Ru Jia; Haiyan Si; Mengjiao Fan; Nan Zhang; Guochao Deng; et al 出版日期:2025-10-12 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)